Redcare Pharmacy NV
XETRA:RDC

Watchlist Manager
Redcare Pharmacy NV Logo
Redcare Pharmacy NV
XETRA:RDC
Watchlist
Price: 144.9 EUR 1.47% Market Closed
Market Cap: 2.9B EUR
Have any thoughts about
Redcare Pharmacy NV?
Write Note

Intrinsic Value

The intrinsic value of one RDC stock under the Base Case scenario is 119.81 EUR. Compared to the current market price of 144.9 EUR, Redcare Pharmacy NV is Overvalued by 17%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RDC Intrinsic Value
119.81 EUR
Overvaluation 17%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Redcare Pharmacy NV

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for RDC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about RDC?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Redcare Pharmacy NV

Provide an overview of the primary business activities
of Redcare Pharmacy NV.

What unique competitive advantages
does Redcare Pharmacy NV hold over its rivals?

What risks and challenges
does Redcare Pharmacy NV face in the near future?

Has there been any significant insider trading activity
in Redcare Pharmacy NV recently?

Summarize the latest earnings call
of Redcare Pharmacy NV.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Redcare Pharmacy NV.

Provide P/S
for Redcare Pharmacy NV.

Provide P/E
for Redcare Pharmacy NV.

Provide P/OCF
for Redcare Pharmacy NV.

Provide P/FCFE
for Redcare Pharmacy NV.

Provide P/B
for Redcare Pharmacy NV.

Provide EV/S
for Redcare Pharmacy NV.

Provide EV/GP
for Redcare Pharmacy NV.

Provide EV/EBITDA
for Redcare Pharmacy NV.

Provide EV/EBIT
for Redcare Pharmacy NV.

Provide EV/OCF
for Redcare Pharmacy NV.

Provide EV/FCFF
for Redcare Pharmacy NV.

Provide EV/IC
for Redcare Pharmacy NV.

Show me price targets
for Redcare Pharmacy NV made by professional analysts.

What are the Revenue projections
for Redcare Pharmacy NV?

How accurate were the past Revenue estimates
for Redcare Pharmacy NV?

What are the Net Income projections
for Redcare Pharmacy NV?

How accurate were the past Net Income estimates
for Redcare Pharmacy NV?

What are the EPS projections
for Redcare Pharmacy NV?

How accurate were the past EPS estimates
for Redcare Pharmacy NV?

What are the EBIT projections
for Redcare Pharmacy NV?

How accurate were the past EBIT estimates
for Redcare Pharmacy NV?

Compare the revenue forecasts
for Redcare Pharmacy NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Redcare Pharmacy NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Redcare Pharmacy NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of Redcare Pharmacy NV compared to its peers.

Compare the P/E ratios
of Redcare Pharmacy NV against its peers.

Discuss the investment returns and shareholder value creation
comparing Redcare Pharmacy NV with its peers.

Analyze the financial leverage
of Redcare Pharmacy NV compared to its main competitors.

Show all profitability ratios
for Redcare Pharmacy NV.

Provide ROE
for Redcare Pharmacy NV.

Provide ROA
for Redcare Pharmacy NV.

Provide ROIC
for Redcare Pharmacy NV.

Provide ROCE
for Redcare Pharmacy NV.

Provide Gross Margin
for Redcare Pharmacy NV.

Provide Operating Margin
for Redcare Pharmacy NV.

Provide Net Margin
for Redcare Pharmacy NV.

Provide FCF Margin
for Redcare Pharmacy NV.

Show all solvency ratios
for Redcare Pharmacy NV.

Provide D/E Ratio
for Redcare Pharmacy NV.

Provide D/A Ratio
for Redcare Pharmacy NV.

Provide Interest Coverage Ratio
for Redcare Pharmacy NV.

Provide Altman Z-Score Ratio
for Redcare Pharmacy NV.

Provide Quick Ratio
for Redcare Pharmacy NV.

Provide Current Ratio
for Redcare Pharmacy NV.

Provide Cash Ratio
for Redcare Pharmacy NV.

What is the historical Revenue growth
over the last 5 years for Redcare Pharmacy NV?

What is the historical Net Income growth
over the last 5 years for Redcare Pharmacy NV?

What is the current Free Cash Flow
of Redcare Pharmacy NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for Redcare Pharmacy NV.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Redcare Pharmacy NV

Current Assets 516.1m
Cash & Short-Term Investments 209.9m
Receivables 104.7m
Other Current Assets 201.5m
Non-Current Assets 502.8m
Long-Term Investments 6.3m
PP&E 80.7m
Intangibles 414.2m
Other Non-Current Assets 1.7m
Current Liabilities 243.9m
Accounts Payable 181.2m
Other Current Liabilities 62.7m
Non-Current Liabilities 269.7m
Long-Term Debt 234.7m
Other Non-Current Liabilities 35m
Efficiency

Earnings Waterfall
Redcare Pharmacy NV

Revenue
2.2B EUR
Cost of Revenue
-1.7B EUR
Gross Profit
516.7m EUR
Operating Expenses
-533m EUR
Operating Income
-16.4m EUR
Other Expenses
-8.2m EUR
Net Income
-24.6m EUR

Free Cash Flow Analysis
Redcare Pharmacy NV

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q3, sales surged by 34% to EUR 1.8 billion, with a remarkable eRx growth rate of 81%, now accelerating to 130% in October. The company recorded an adjusted EBITDA margin of 2%, impacted by increased marketing efforts, while year-to-date EBITDA stands at 2.3%. Non-Rx sales exceeded 20% growth, prompting a revised guidance for full-year sales to between EUR 2.35 billion and EUR 2.5 billion. Active customers grew to 12 million, reflecting sustained demand. The company aims to enhance market share in the addressable EUR 55 billion Rx market from the current 0.66%.

What is Earnings Call?
Fundamental Scores

RDC Profitability Score
Profitability Due Diligence

Redcare Pharmacy NV's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
Positive Gross Profit
Exceptional 1-Year Revenue Growth
41/100
Profitability
Score

Redcare Pharmacy NV's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

RDC Solvency Score
Solvency Due Diligence

Redcare Pharmacy NV's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Short-Term Solvency
Long-Term Solvency
57/100
Solvency
Score

Redcare Pharmacy NV's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RDC Price Targets Summary
Redcare Pharmacy NV

Wall Street analysts forecast RDC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RDC is 160.72 EUR with a low forecast of 85.85 EUR and a high forecast of 212.1 EUR.

Lowest
Price Target
85.85 EUR
41% Downside
Average
Price Target
160.72 EUR
11% Upside
Highest
Price Target
212.1 EUR
46% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for RDC?

Click here to dive deeper.

Dividends

Redcare Pharmacy NV
does not pay dividends
Shareholder Yield

Current shareholder yield for RDC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

RDC Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Redcare Pharmacy NV Logo
Redcare Pharmacy NV

Country

Netherlands

Industry

Retail

Market Cap

2.9B EUR

Dividend Yield

0%

Description

Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. The company is headquartered in Sevenum, Limburg and currently employs 1,847 full-time employees. The company went IPO on 2016-10-13. The firm focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The firm is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.

Contact

LIMBURG
Sevenum
Erik de Rodeweg 11/13
shop-apotheke-europe.com

IPO

2016-10-13

Employees

1 847

Officers

CEO & Member of the Managing Board
Mr. Olaf Heinrich
Co-Founder & Advisor
Mr. Marc Fischer
CFO & Member of Management Board
Mr. Jasper F. P. Eenhorst
COO & Member of the Managing Board
Ms. Theresa Holler
Chief Commercial Officer & Member of Management Board
Mr. Dirk Bruse
Chief Information Officer & Member of Management Board
Mr. Lode Fastré
Show More
Associate Director of Investor Relations
Monica Ambrosi
Chief Sales Officer
Mr. Patrick Schneider
Director of Human Resources
Ms. Beate Krosch
Show Less

See Also

Discover More
What is the Intrinsic Value of one RDC stock?

The intrinsic value of one RDC stock under the Base Case scenario is 119.81 EUR.

Is RDC stock undervalued or overvalued?

Compared to the current market price of 144.9 EUR, Redcare Pharmacy NV is Overvalued by 17%.

Back to Top